Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats

BACKGROUND: We previously have shown that glibenclamide (GBC), a sulfonylurea receptor 1–transient receptor potential M4 (SUR1‐TRPM4) channel inhibitor, improves survival and neurological outcome after asphyxial cardiac arrest and cardiopulmonary resuscitation (ACA/CPR). Here, we further compare the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Heart Assoc
Главные авторы: Huang, Kaibin, Wang, Ziyue, Gu, Yong, Hu, Yafang, Ji, Zhong, Wang, Shengnan, Lin, Zhenzhou, Li, Xing, Xie, Zuoshan, Pan, Suyue
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015382/
https://ncbi.nlm.nih.gov/pubmed/27413041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003465
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы